# Strawberry Fields REIT, Inc.: financial statements, quarterly

STRW · NYSE · CIK 1782430 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/strw.md) · [Financials](/companies/strw/financials.md) · [Filings](/companies/strw/filings.md) · [Insiders](/companies/strw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/strw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [25.8](/filings/0001493152-24-044262.md) | [25.5 d](/filings/0001493152-25-010144.md) | [27.8](/filings/0001641172-25-009352.md) | [29.3](/filings/0001641172-25-022675.md) | [29.5](/filings/0001493152-25-021088.md) | [30.5 d](/filings/0001493152-26-011682.md) | [37.3](/filings/0001493152-26-021823.md) | [37.9](/filings/0001493152-26-036400.md) | [39.7](/filings/0001493152-25-021088.md) | [40.1 d](/filings/0001493152-26-011682.md) | [40.0](/filings/0001493152-26-021823.md) | [40.0](/filings/0001493152-26-036400.md) |
| Operating income | $m | [13.1](/filings/0001493152-24-044262.md) | [12.4 d](/filings/0001493152-25-010144.md) | [14.3](/filings/0001641172-25-009352.md) | [15.3](/filings/0001641172-25-022675.md) | [16.0](/filings/0001493152-25-021088.md) | [15.7 d](/filings/0001493152-26-011682.md) | [20.2](/filings/0001493152-26-021823.md) | [20.6](/filings/0001493152-26-036400.md) | [22.5](/filings/0001493152-25-021088.md) | [21.0 d](/filings/0001493152-26-011682.md) | [22.1](/filings/0001493152-26-021823.md) | [21.5](/filings/0001493152-26-036400.md) |
| Interest expense | $m | [8.4](/filings/0001493152-24-044262.md) | [7.0 d](/filings/0001493152-25-010144.md) | [8.3](/filings/0001641172-25-009352.md) | [8.3](/filings/0001641172-25-022675.md) | [9.1](/filings/0001493152-25-021088.md) | [9.1 d](/filings/0001493152-26-011682.md) | [13.2](/filings/0001493152-26-021823.md) | [12.0](/filings/0001493152-26-036400.md) | [13.6](/filings/0001493152-25-021088.md) | [12.2 d](/filings/0001493152-26-011682.md) | [12.7](/filings/0001493152-26-021823.md) | [12.4](/filings/0001493152-26-036400.md) |
| Net income | $m | [0.6](/filings/0001493152-24-044262.md) | [0.7 d](/filings/0001493152-25-010144.md) | [0.7](/filings/0001641172-25-009352.md) | [0.9](/filings/0001641172-25-022675.md) | [0.9](/filings/0001493152-25-021088.md) | [1.5 d](/filings/0001493152-26-011682.md) | [1.6](/filings/0001493152-26-021823.md) | [2.0](/filings/0001493152-26-036400.md) | [2.0](/filings/0001493152-25-021088.md) | [2.0 d](/filings/0001493152-26-011682.md) | [2.3](/filings/0001493152-26-021823.md) | [2.2](/filings/0001493152-26-036400.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001493152-24-044262.md) | not reported | [0.12](/filings/0001641172-25-009352.md) | [0.14](/filings/0001641172-25-022675.md) | [0.14](/filings/0001493152-25-021088.md) | not reported | [0.13](/filings/0001493152-26-021823.md) | [0.16](/filings/0001493152-26-036400.md) | [0.16](/filings/0001493152-25-021088.md) | not reported | [0.17](/filings/0001493152-26-021823.md) | [0.16](/filings/0001493152-26-036400.md) |
| Basic EPS | $ per share | [0.09](/filings/0001493152-24-044262.md) | not reported | [0.12](/filings/0001641172-25-009352.md) | [0.14](/filings/0001641172-25-022675.md) | [0.14](/filings/0001493152-25-021088.md) | not reported | [0.13](/filings/0001493152-26-021823.md) | [0.16](/filings/0001493152-26-036400.md) | [0.16](/filings/0001493152-25-021088.md) | not reported | [0.17](/filings/0001493152-26-021823.md) | [0.16](/filings/0001493152-26-036400.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.5](/filings/0001493152-23-040248.md) | [12.2](/filings/0001493152-25-010144.md) | [15.1](/filings/0001493152-24-019017.md) | [16.1](/filings/0001493152-24-031111.md) | [29.3](/filings/0001493152-24-044262.md) | [48.4](/filings/0001493152-26-011682.md) | [42.3](/filings/0001641172-25-009352.md) | [96.3](/filings/0001641172-25-022675.md) | [19.8](/filings/0001493152-25-021088.md) | [31.8](/filings/0001493152-26-036400.md) | [36.6](/filings/0001493152-26-021823.md) | [42.2](/filings/0001493152-26-036400.md) |
| Total assets | $m | [630](/filings/0001493152-23-040248.md) | [617](/filings/0001493152-25-010144.md) | [635](/filings/0001493152-24-019017.md) | [636](/filings/0001493152-24-031111.md) | [662](/filings/0001493152-24-044262.md) | [788](/filings/0001493152-26-011682.md) | [835](/filings/0001641172-25-009352.md) | [897](/filings/0001641172-25-022675.md) | [881](/filings/0001493152-25-021088.md) | [885](/filings/0001493152-26-036400.md) | [879](/filings/0001493152-26-021823.md) | [878](/filings/0001493152-26-036400.md) |
| Total liabilities | $m | [576](/filings/0001493152-23-040248.md) | [570](/filings/0001493152-25-010144.md) | [587](/filings/0001493152-24-019017.md) | [585](/filings/0001493152-24-031111.md) | [606](/filings/0001493152-24-044262.md) | [704](/filings/0001493152-26-011682.md) | [748](/filings/0001641172-25-009352.md) | [831](/filings/0001641172-25-022675.md) | [818](/filings/0001493152-25-021088.md) | [835](/filings/0001493152-26-036400.md) | [828](/filings/0001493152-26-021823.md) | [846](/filings/0001493152-26-036400.md) |
| Long-term debt | $m | [546](/filings/0001493152-23-040248.md) | [539](/filings/0001493152-24-010409.md) | [560](/filings/0001493152-24-019017.md) | [555](/filings/0001493152-24-031111.md) | [585](/filings/0001493152-24-044262.md) | [674](/filings/0001493152-25-010144.md) | [715](/filings/0001641172-25-009352.md) | [794](/filings/0001641172-25-022675.md) | [779](/filings/0001493152-25-021088.md) | [795](/filings/0001493152-26-011682.md) | [791](/filings/0001493152-26-021823.md) | [810](/filings/0001493152-26-036400.md) |
| Shareholders' equity | $m | [8.4](/filings/0001493152-23-040248.md) | [7.5](/filings/0001493152-25-010144.md) | [7.5](/filings/0001493152-24-019017.md) | [7.4](/filings/0001493152-24-031111.md) | [12.6](/filings/0001493152-24-044262.md) | [18.2](/filings/0001493152-26-011682.md) | [19.6](/filings/0001641172-25-009352.md) | [15.5](/filings/0001641172-25-022675.md) | [14.2](/filings/0001493152-25-021088.md) | [12.1](/filings/0001493152-26-036400.md) | [12.2](/filings/0001493152-26-021823.md) | [8.3](/filings/0001493152-26-036400.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.5 d](/filings/0001493152-24-044262.md) | [12.9 d](/filings/0001493152-25-010144.md) | [2.1](/filings/0001641172-25-009352.md) | [20.6 d](/filings/0001641172-25-022675.md) | [11.8 d](/filings/0001493152-25-021088.md) | [24.8 d](/filings/0001493152-26-011682.md) | [19.0](/filings/0001493152-26-021823.md) | [29.8 d](/filings/0001493152-26-036400.md) | [20.7 d](/filings/0001493152-25-021088.md) | [20.6 d](/filings/0001493152-26-011682.md) | [17.5](/filings/0001493152-26-021823.md) | [24.2 d](/filings/0001493152-26-036400.md) |
| Share repurchases | $m | not reported | not reported | [0.2](/filings/0001641172-25-009352.md) | [0.5 d](/filings/0001641172-25-022675.md) | [0.2 d](/filings/0001493152-25-021088.md) | [1.6 d](/filings/0001493152-26-011682.md) | not reported | not reported | [0.0 d](/filings/0001493152-25-021088.md) | [0.0 d](/filings/0001493152-26-011682.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.0](/filings/0001493152-23-040248.md) | [6.4](/filings/0001493152-24-019017.md) | [6.4](/filings/0001493152-24-031111.md) | [6.4](/filings/0001493152-24-044262.md) | [6.5](/filings/0001641172-25-009352.md) | [6.5](/filings/0001641172-25-022675.md) | [7.0](/filings/0001493152-25-021088.md) | [12.2](/filings/0001493152-26-021823.md) | [12.5](/filings/0001493152-26-036400.md) | [13.0](/filings/0001493152-25-021088.md) | [13.3](/filings/0001493152-26-021823.md) | [13.5](/filings/0001493152-26-036400.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,157,336 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001493152-26-036400.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.